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Abstract The effect of hyperphosphorylation on the structural
properties and conformational stability of bovine tau-protein was
studied by means of circular dichroism and fluorescence lifetime
techniques. Normal protein contains unusual secondary structure
elements: extended left-handed helices. The structure of this
protein was assumed to be of a ‘tadpole’ type ^ a globular C-
terminal part with a long and rigid tail included in the extended
left-handed helix. Either a decrease or an increase of pH induced
only minor changes of the normal tau-protein surface. Hyper-
phosphorylation affected the extended part of the protein
molecule; the decrease of pH in this case induced considerable
structural rearrangements, and the conformation of the C-
terminal part of the protein molecule was transformed into a
molten globule-like state.
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1. Introduction
Cytoplasmic microtubules are found in all eukaryotic cells.
They play an important role in the maintenance of cell shape,
cell division, axonal transport, secretion, and receptor activity
[1]. The structure of microtubules, being determined by the
polymerisation of tubulin dimers, is very dynamic. These ¢l-
aments are stabilised by a number of accessory proteins
(known as MAPs, microtubule-associated proteins). Microtu-
bules are considerably more abundant in nerve cells, where
they are involved in intraneuronal transport. Among the fac-
tors that distinguish neuronal microtubules from non-neuro-
nal ¢laments is the presence of a set of neuronal-speci¢c
MAPs [2]. Tau-proteins are potential representatives of this
collection [3]. The presence of tau-protein is essential for both
nucleation and elongation of the ¢laments [4,5]. It was shown
that tau-proteins bind microtubules by repetitive sequences in
their C-terminal area [6]. The importance of phosphorylation
for regulation of the catalytic activity of tau-protein was sug-
gested. It was shown that hypophosphorylated tau-proteins
are capable of tubulin polymerisation, whereas hyperphos-
phorylated forms catalyse the depolymerisation of microtu-
bules into tubulin [7].
The interest in tau-proteins has been dramatically increased
by the discovery of MAP aggregation in neuronal cells in the
progress of Alzheimer’s disease and various other neurodege-
nerative disorders. In these cases speci¢c tau-protein-contain-
ing neuro¢brillary tangles were shown to be formed [7].
The tau-protein isolated from brain microtubules represents
a family of proteins which migrate during SDS gel electro-
phoresis as close bands of 55^62 kDa molecular weight [8].
Heterogeneity is explained in part by alternative mRNA splic-
ing leading to the appearance of one, two, three or four re-
peats in the C-terminal region of a protein molecule [9]. Post-
translational phosphorylation of tau-protein should be con-
sidered an additional source of microheterogeneity in SDS
gel electrophoretic experiments [8,10]. The phosphorylation-
dephosphorylation cycle plays an important role in regulation
of tau-protein activity [10]. Analysis of the paracrystalline
structure of the tau-protein suggested that the protein mole-
cule became longer and more rigid with increasing degree of
phosphorylation [11]. Increased phosphorylation was shown
to be a common characteristic of a pathological tau-protein
[12^15]. An important role of proline-directed MAP kinases
(recognising sequences of -X-(Ser/Thr)-Pro-X-) in tau-protein
phosphorylation has been demonstrated [14]. Interestingly, the
largest isoform of human tau-protein contains at least 14 po-
tential sites for phosphorylation by such kinases.
As shown by analytical ultracentrifugation and sedimenta-
tion studies, the native tau-protein isoform with a molecular
weight of 57 kDa has a sedimentation coe⁄cient of 2.6 S. It
favours a highly asymmetric structure with an axial ratio (cal-
culated on the basis of an assumed prolate ellipsoid model) of
20:1 [16].
Although biological and biochemical aspects of tau-protein
functioning and its involvement in the development of various
neurodegenerative disorders have been extensively studied,
only little is known about conformational changes induced
by phosphorylation. The aim of this work was to study struc-
tural changes of the tau-protein molecule resulting from hy-
perphosphorylation.
2. Materials and methods
2.1. Materials
We used bovine tau-protein from Sigma-Aldrich GmbH (Deisen-
hofen, Germany; Lot #107H4011); activated proline-directed MAP
kinase from Stratagene GmbH (Heidelberg, Germany; Lot #206115);
[Q-32P]ATP was from ICN Biomedicals GmbH (Eschwege, Germany).
Protein concentrations of 5 and 0.5 WM were kept throughout all
the circular dichroism (CD) and £uorescence experiments, respec-
tively. 8-Anilino-1-naphthalene sulphonate (8-ANS) concentration
was 5 WM. Measurements were performed at 23‡C.
2.2. Instrumentation
Circular dichroism measurements were carried out by means of a
JASCO-700 spectropolarimeter (Japan Spectroscopic Co., Tokyo,
Japan), using a cuvette with a light path of 0.1 mm. Protein concen-
tration was kept at 0.1 mg/ml throughout all experiments. Steady-
state measurements of 8-ANS were performed using a SFM-25 spec-
tro£uorimeter (Tegimenta AG, Switzerland). Decay times of ANS
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£uorescence were measured by means of the time domain £uorescence
lifetime method. The frequency-tripled output of a titanium sapphire
laser Tsunami (Spectra Physics, Mountain View, CA, USA) was used
for the excitation of £uorescence. The laser was run in mode-locked
operation at 82 MHz producing pulses of 250 fs pulse width with an
averaged energy of 42 mW at 263 nm wavelength. The £uorescence
decay was recorded by a streak camera C4334 (Hamamatsu, Japan) in
the 10 ns time window. The £uorescence emission was spectrally re-
solved by a polychromator in front of the streak camera.
2.3. Phosphorylation of tau-protein with activated proline-directed
MAP kinase
Tau-protein (5 WM) was phosphorylated by activated MAP kinase
under standard conditions (25 mM HEPES, 10 mM magnesium ace-
tate, 100 WM ATP (or [Q-32P]ATP), pH 7.5) using 0.01 WM of acti-
vated MAP kinase. The reaction mixture was incubated for 24 h at
30‡C. The ¢nal volume of the reaction mixture was 200 Wl in the case
of ATP and 20 Wl in the case of [Q-32P]ATP. In the latter case the
sample was mixed with SDS sample bu¡er and analysed on a 10%
SDS polyacrylamide gel [17]. The gel was stained with Coomassie
brilliant blue R, washed o¡, dried and analysed by autoradiography.
It has been established that practically all Q-32P was bound by the tau-
protein at the given conditions. It allows us to estimate the degree of
tau-protein phosphorylation to be approximately 20.
3. Results
3.1. Tau-protein molecule contains an extended left-handed
helix as an element of secondary structure
As seen from Fig. 1, the far-UV CD spectrum of the nor-
mal bovine tau-protein di¡ers signi¢cantly from the far-UV
CD spectra common for globular proteins. This suggests that
tau-protein contains speci¢c (unusual) secondary structure el-
ements, e.g. stretched left-handed helical structures of the
poly-L-proline type [18]. This is supported, ¢rst, by the ex-
tended highly asymmetric shape of the tau-protein molecule
[16]; second, by the extremely high content of proline residues
mainly concentrated in the middle part of the protein mole-
cule.
The presence of extended left-handed helical elements in the
tau-protein molecule was con¢rmed by further analysis of its
far-UV CD spectrum. The content of common secondary
structure elements (K-helix and L-structure) in the tau-protein
molecule was estimated from the amino acid sequence, using
the ALB software [20]. As shown by this analysis, tau-protein
has a relatively low content of ordered secondary structures
(15% K-helix and 10% L-structure). The reconstructed spec-
trum comprising 15% K-helix, 10% L-structure and 75% ran-
dom coil did not ¢t the experimentally obtained spectrum,
especially in the short-wave region (Fig. 1). All our attempts
to obtain a spectrum resembling that of the tau-protein have
failed for the content of K-helical and L-structural elements
between 5 and 45%. This discrepancy can be explained by the
presence of unusual structural elements not taken into ac-
count in the modelling approach. Let us assume that approx-
imately 25% of protein amino acid residues are involved in an
extended left-handed helical structure. Since the spectrum of
the left-handed helix was determined earlier [18], we tried to
restore the far-UV CD spectrum of tau-protein as a sum of
spectra of elementary structures with weight coe⁄cients of 15,
10, 25 and 50 for K-helix, L-structure, extended left-handed
helix and random coil, respectively (Fig. 1). The restored spec-
trum was rather close to the measured one. Therefore, the
extended left-handed helical structure appears to be one of
the structural elements of the normal tau-protein.
3.2. E¡ect of pH on normal tau-protein structure
As seen from Fig. 2, far-UV CD spectra of bovine tau-
protein demonstrate no signi¢cant alterations in the pH range
from 2.5 to 10.0. Some additional information of the pH e¡ect
on structural properties of tau-protein was obtained by ana-
lysing the interaction of this protein with the hydrophobic
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Fig. 1. Far-UV CD spectrum of bovine tau-protein (bold line) and
spectra resulting from the composition of model spectra of elemen-
tary structures: 15% K-helix+10% L-structure+75% random coil
(dashed line); 15% K-helix+10% L-structure+25% extended left-
handed helix+50% random coil (dash-dotted line). Inset represents
model spectra for K-helix [19], L-structure [19], random coil [19] and
extended left-handed helix [18] (bold, dotted, dashed and dash-dot-
ted lines, respectively).
Fig. 2. Far-UV CD spectra in the limited wavelength range meas-
ured for normal tau-protein at di¡erent pH values: pH 2.5, 7.5 and
10.0 (solid, dotted and dashed lines, respectively). Inset represents
the full-scale spectra measured at the same conditions.
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£uorescent probe 8-ANS. It is known that the £uorescence
intensity of 8-ANS increases considerably upon interaction
with large water-inaccessible hydrophobic clusters of the pro-
tein molecules [21,22]. Non-native conformations of globular
proteins (like the molten globule intermediate state) were
shown to have a higher a⁄nity for 8-ANS than native and
unfolded molecules [22]. It was also established that the decay
time of free 8-ANS in aqueous solution is about 0.3 ns, where-
as the formation of the probe-protein complexes yields a 10^
60-fold increase in decay time [23]. The existence of at least
two di¡erent types of 8-ANS-protein complexes was de-
scribed. Upon the formation of complexes of the ¢rst type,
the 8-ANS molecule interacts with the surface of the protein
molecule and is relatively well accessible to the solvent. These
complexes are characterised by a decay time of 2^5 ns. Being
involved in the formation of complexes of the second type, the
8-ANS molecule is embedded into the protein molecule and
practically inaccessible to water. The characteristic lifetime of
8-ANS £uorescence in this case will be V10 ns for the native
proteins and V15^20 ns for the molten globule proteins [23].
We have used these observations to analyse the pH-induced
structural transformations of a tau-protein molecule. The re-
sults of these investigations are summarised in Fig. 3. It can
be seen that in the pH range between 3.0 and 9.0 there is no
8-ANS-protein interaction. Fig. 3 also shows a considerable
change in both £uorescence parameters (intensity and lifetime)
beyond this pH range, probably due to structural changes of
the protein molecule and to the formation of 8-ANS-protein
complexes. As in these cases the lifetime of 8-ANS £uores-
cence is about 4 ns, we may conclude that the formation of
complexes of the ¢rst type took place. In other words, the pH-
induced structural transformation of the tau-protein is only
small and the major part of the protein molecule remains
practically immutable and preserves a relatively rigid struc-
ture.
3.3. E¡ect of hyperphosphorylation on tau-protein structure
and stability
Far-UV CD spectra of normal and hyperphosphorylated
forms of bovine tau-protein at di¡erent pH are presented in
Fig. 4. The left-hand part of Fig. 4 shows that at neutral pH
the minimum at 202 nm, characteristic for the normal tau-
protein, is practically absent in the spectrum of the hyper-
phosphorylated protein. This tempted us to suppose that ma-
jor hyperphosphorylation-induced changes of the tau-protein
can be expected in the extended part of the protein molecule.
As follows from the right-hand part of Fig. 4, the far-UV
CD spectrum of hyperphosphorylated protein at pH 4.0 is
very close to that of the normal protein at pH 2.0. A further
pH decrease leads to additional spectral changes, e.g. a 2-nm
shift is observed of the minimum to longer wavelengths, ac-
companied by a considerable increase in the corresponding
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Fig. 4. Far-UV CD spectra of normal and hyperphosphorylated forms of bovine tau-protein measured at di¡erent pH values. Left, neutral
pH; right, acidic pH.
Fig. 3. E¡ect of pH on the £uorescence parameters of the hydro-
phobic £uorescent probe 8-ANS in the presence of normal and hy-
perphosphorylated tau-protein (grey and open symbols, respec-
tively). Arrow indicates the level of free 8-ANS £uorescence.
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negative ellipticity ([a]222 =34800 and 37000 deg cm2/dmol at
pH 4.0 and 2.0, respectively).
8-ANS £uorescence parameters, determined for normal and
hyperphosphorylated tau-proteins, behave quite di¡erently in
their response to decreasing pH (see Fig. 3). It was already
noted that both a decrease and an increase in pH a¡ect the
structure of normal tau-protein equally, resulting only in some
changes of the protein molecule surface. It can be seen that a
comparable structural rearrangement can be expected for the
hyperphosphorylated tau-protein at high (pHs 9.0) or mod-
erately low (pH between 4.0 and 3.0) pH values, while a
further decrease of the pH value leads to an additional struc-
tural transformation of this form of protein (Fig. 3). This
means that the decrease in pH value induces two consecutive
conformational transitions in the hyperphosphorylated tau-
protein: to the end of ¢rst (pH 4.0) and second transition
(pH 2.0) the intensity of 8-ANS £uorescence increases
3- and 20-fold, respectively (Fig. 3). Interestingly, 8-ANS £uo-
rescence lifetimes were 0.3, 4.4 and 18.5 ns at pH 7.5, 3.8 and
1.7, respectively. Fluorescence lifetimes longer than 10 ns cor-
respond to the protein-embedded 8-ANS molecules [23].
When exceeding 15 ns, the 8-ANS molecules are placed in a
highly £exible hydrophobic environment (like in a non-polar
protic solvent). Such a situation was assumed to occur upon
the transformation of a protein molecule into the molten glob-
ule state [23].
4. Discussion
Our data show that upon a decrease of the pH value the
hyperphosphorylated tau-protein undergoes a two-step struc-
tural transformation. At the ¢rst step (pH 4.0) the solvent-
accessible hydrophobic clusters appear on the surface of the
relatively rigid protein molecule. At the second step (pH 2.0)
the protein molecule is transformed into a highly £exible con-
formation with a pronounced secondary structure. The nature
of this conformation (molten globule-like intermediate) would
be obvious if we had worked with a usual globular protein.
However, with tau-protein the situation is more complicated.
Indeed, it was already noted that the tau-protein molecule is
highly asymmetric [16]. This gives rise to several important
questions. Can we expect the appearance of the structural
transformations described within a single protein molecule
or is the hydrophobic environment in which 8-ANS becomes
embedded created by the formation of protein associates? If,
nevertheless, such structural transformations take place within
a protein molecule, which part of it can be a¡ected?
The well-known feature of the hyperphosphorylated tau-
protein is its trend to form neuro¢brillary tangles responsible
for the development of several neurodegenerative disorders
[7]. Paired helical ¢laments (PHF) are the major component
of these neuro¢brillary deposits [12]. It is a widespread belief
that hyperphosphorylation of the tau-proteins is just the proc-
ess preceding formation of the PHF [24]. Quite recently it was
established that the appearance of PHF in vitro required the
presence of sulphated glycosaminoglycans (heparin). More-
over, in this case PHF was found to be formed both from
normal and from hyperphosphorylated forms of tau-protein
with nearly equal e⁄ciency. On the other hand, in the absence
of heparin, ¢lament appearance was not observed even in the
case of hyperphosphorylated tau-protein [25]. This observa-
tion is in a good agreement with our data ^ we did not see
any substantial light scattering from the solutions of either
normal or hyperphosphorylated tau-protein. This fact favours
the absence of large protein associates in both cases. Conse-
quently, there are some hints to assume that decreasing pH
induces considerable intramolecular conformational transfor-
mations in the molecule of hyperphosphorylated tau-protein.
In which part of an extended protein molecule can we ex-
pect the development of such structural changes? To answer
this question the analysis of secondary structure element local-
isation within the amino acid sequence was applied. Results of
such a prediction from the program ALB [20] have shown
that the distribution of the secondary structure within the
sequence of tau-protein is extremely uneven. The highest
probability to be involved in the formation of a regular sec-
ondary structure is characteristic for the C-terminal part of a
protein molecule, known as a microtubule assembly domain,
containing several highly conserved 18-acid repeats. It is di⁄-
cult to exclude that the normal tau-protein molecule has the
‘tadpole’ shape, i.e. it includes the globular C-terminal part
with up to 50% of amino acid residues and a relatively long
and rigid tail, the main part of which is a constituent of the
extended left-handed helix.
Hyperphosphorylation leads to some perturbation within
the extended part of a protein molecule, whereas its C-termi-
nal part remains practically unchanged. With decreasing pH
the hyperphosphorylated protein undergoes considerable
structural rearrangements and the C-terminal part of a mole-
cule is transformed into the molten globule-like conformation.
If this is true, it is quite reasonable to suggest that just the C-
terminal part of hyperphosphorylated tau-protein is responsi-
ble for the association of protein molecules. Indeed, it is
known that the capability to associate (or aggregate) is the
speci¢c property of partially folded conformations of globular
proteins [26^34]. Considerable structural transformations and
an increase in conformational stability of a protein molecule
can be observed as the results of the association [32^34].
Taking all this into account, we assume that at de¢nite cell
conditions (e.g. near the membrane surface) hyperphosphoryl-
ated tau-protein molecules undergo structural changes, which
transform the C-terminal part of a protein molecule into the
molten globule-like state. This may cause association of the
tau-protein molecules and formation of the paired helical ¢l-
aments. If so, tau-protein molecules within PHF should be
stacked ‘head-to-head’, ensuring the best contact of their hy-
drophobic surfaces. Interestingly, it was shown by immunoe-
lectron microscopy that monoclonal antibodies against di¡er-
ent parts of tau-protein di¡er in their ability to interact with
the paired helical ¢laments. In particular, PHF was e¡ectively
decorated by antibodies directed against the amino-terminus
of tau-protein, but not by the antibody against the microtu-
bule-binding repeat region. It was concluded that in ¢laments
the repeat region of tau-protein is inaccessible to the antibod-
ies [25,35].
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